Loading provider…
Loading provider…
Internal Medicine Physician in San Francisco, CA
NPI: 1033176581Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get MD Hope's Phone Numberphone_androidMobile
Get MD Hope's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1986 - 2026
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1984
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Hematology and Medical Oncology
1987 - 1990
Residency • Internal Medicine
1984 - 1987
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Authors: William Symmans, Laura Esserman, Michael Hogarth, Tufia Haddad, Amy Chien, Donald Northfelt, Judy Boughey, Anne Wallace, Barbara Haley, Cheryl Ewing, Richard Schwab, Douglas Yee
Publication Date: 2016-07
Palbociclib and Letrozole in Advanced Breast Cancer
Authors: Dennis Slamon, Richard Finn
Journal: N Engl J Med
Lead Sponsor: Massachusetts General Hospital
Collaborators: Pfizer
Intervention / Treatment: DRUG: Talazoparib
Lead Sponsor: Laura Huppert, MD, BA
Collaborators: Gilead Sciences, Hoosier Cancer Research Network, Pfizer, Breast Cancer Research Foundation, Johns Hopkins University, Translational Breast Cancer Research Consortium, Array BioPharma
Intervention / Treatment: BIOLOGICAL: Anti-OX40 Antibody PF-04518600, DRUG: Avelumab, DRUG: Sacituzumab Govitecan, BIOLOGICAL: Utomilumab, DRUG: Liposomal Doxorubicin, DRUG: Binimetinib
Lead Sponsor: OBI Pharma, Inc
Intervention / Treatment: BIOLOGICAL: adagloxad simolenin combined with OBI-821, DEVICE: Globo H IHC Assay, OTHER: Standard of care treatment